The wing shows severe reductions in size, increased extra vein tissue, and loss of intervein territories in a dose-sensitive manner in response to increased levels of osaC819 under the control of Scer\GAL4salm-459.2. Severity: Scer\GAL4salm-459.2; osaC819 > Scer\GAL4salm-459.2; osaC819/+ > Scer\GAL4salm-459.2/+; osaC819/+.
Expression of C819C819 under the control of Scer\GAL4dpp.3KK results in wing vein thickening.
Expression of C819C819 under the control of Scer\GAL4MD-638 results in wing vein thickening.
Expression of C819C819 under the control of Scer\GAL4sca-C253 does not result in a mutant phenotype.
osaC819/Scer\GAL4MD-638 is an enhancer of wing vein | ectopic phenotype of bs2
Overexpression of osaC819 by Scer\GAL4MD-638 enhances the ectopic veins observed in bs2 mutant animals.
Selected as: a P{GSV1} insertion line that when expressed using Scer\GAL4dpp.3KK results in a mutant phenotype in the wing.
Separable from: another five P{GSV1} insertions.